AU2175400A - Method for the use of cherry isolates providing antioxidant phytoceutical or nutraceutical benefits - Google Patents

Method for the use of cherry isolates providing antioxidant phytoceutical or nutraceutical benefits

Info

Publication number
AU2175400A
AU2175400A AU21754/00A AU2175400A AU2175400A AU 2175400 A AU2175400 A AU 2175400A AU 21754/00 A AU21754/00 A AU 21754/00A AU 2175400 A AU2175400 A AU 2175400A AU 2175400 A AU2175400 A AU 2175400A
Authority
AU
Australia
Prior art keywords
phytoceutical
cherry
isolates
providing antioxidant
nutraceutical benefits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21754/00A
Other languages
English (en)
Inventor
Alden M. Booren
James I. Gray
Muraleedharan G. Nair
Gale M. Strasburg
Haibo Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Michigan State University MSU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/317,310 external-priority patent/US6423365B1/en
Priority claimed from US09/329,604 external-priority patent/US6150408A/en
Application filed by Michigan State University MSU filed Critical Michigan State University MSU
Publication of AU2175400A publication Critical patent/AU2175400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU21754/00A 1998-12-11 1999-12-10 Method for the use of cherry isolates providing antioxidant phytoceutical or nutraceutical benefits Abandoned AU2175400A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US11194598P 1998-12-11 1998-12-11
US60111945 1998-12-11
US12017899P 1999-02-16 1999-02-16
US60120178 1999-02-16
US09317310 1999-05-24
US09/317,310 US6423365B1 (en) 1998-12-11 1999-05-24 Method and compositions producing cherry derived products
US09/329,604 US6150408A (en) 1998-12-11 1999-06-10 Tart cherry compounds that have antioxidant activity and uses thereof
US09329604 1999-06-10
US34207699A 1999-06-28 1999-06-28
US09342076 1999-06-28
PCT/US1999/029440 WO2000033667A2 (fr) 1998-12-11 1999-12-10 Mode d'utilisation d'isolats de cerise aux proprietes phytoceutiques ou nutraceutiques antioxydantes

Publications (1)

Publication Number Publication Date
AU2175400A true AU2175400A (en) 2000-06-26

Family

ID=27537321

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21754/00A Abandoned AU2175400A (en) 1998-12-11 1999-12-10 Method for the use of cherry isolates providing antioxidant phytoceutical or nutraceutical benefits

Country Status (5)

Country Link
JP (1) JP2002531473A (fr)
CN (1) CN100394916C (fr)
AU (1) AU2175400A (fr)
TW (1) TWI223982B (fr)
WO (1) WO2000033667A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269421C (zh) * 1998-12-11 2006-08-16 密执安州大学 生产源于浆果的产物的方法和组合物
EP1307212B1 (fr) * 2000-07-31 2007-03-28 World Resources Corporation Antioxydants derives de plantes
US7306815B2 (en) * 2000-08-31 2007-12-11 Phenolics, Llc Compositions enriched in phenolic compounds and methods for producing the same
GB0127032D0 (en) 2001-11-09 2002-01-02 Medpalett Pharmaceuticals As Product
GB0316757D0 (en) * 2003-07-17 2003-08-20 Biochem Lab As Use
US7737121B2 (en) * 2004-07-29 2010-06-15 Board Of Trustees Of Michigan State University Insulin secretion by anthocyanins and anthocyanidins
EP2108692A1 (fr) * 2008-04-11 2009-10-14 Brasseries Kronenbourg Procédé d'obtention d'extraits concentrés en polyphénols issus du procédé de brassage
JP2015051934A (ja) * 2013-09-05 2015-03-19 地方独立行政法人青森県産業技術センター 皮膚の酸化的ストレス抑制剤
CN112624928B (zh) * 2021-01-21 2023-03-17 黄河科技学院 一种抗凝血桃花有效成分及其应用
CN114990168B (zh) * 2021-08-24 2023-05-26 灶灶科技有限公司 酸樱桃发酵制得的具有良好保健功能的组合物及其在健康领域的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE113477T1 (de) * 1990-08-20 1994-11-15 Ohlenschlaeger Gerhard Therapeutisch wirksames stoffgemisch aus glutathion- und anthocyan-verbindungen.
JPH06248267A (ja) * 1993-02-24 1994-09-06 S I I Techno Res:Yugen 新規抗酸化剤
JPH06271850A (ja) * 1993-03-23 1994-09-27 Nikken Food Kk 天然物を原料とした抗酸化剤およびその製造方法
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
DE19720767A1 (de) * 1997-05-07 1998-11-12 Protekum Umweltinstitut Gmbh O Pharmazeutisches Produkt, insbesondere zur Therapie und Prophylaxe von Herz-Kreislauf-Erkrankungen

Also Published As

Publication number Publication date
CN1334740A (zh) 2002-02-06
WO2000033667A2 (fr) 2000-06-15
WO2000033667A3 (fr) 2000-08-31
JP2002531473A (ja) 2002-09-24
CN100394916C (zh) 2008-06-18
TWI223982B (en) 2004-11-21

Similar Documents

Publication Publication Date Title
AU1623200A (en) Method for identifying the language of individual words
AU2301699A (en) System for the treatment of wafers
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU6167899A (en) Biopsy apparatus
AU2001279701A1 (en) Method for protecting the skin from aging
AU3077699A (en) Apparatus for performing hippotherapy
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU2001297856A1 (en) Method for determining homeostasis of the skin
AU2479699A (en) Method for the determination of oxidative stress
AU2175400A (en) Method for the use of cherry isolates providing antioxidant phytoceutical or nutraceutical benefits
AU3444899A (en) Method for the rapid determination of bacteria
AU6105199A (en) Diagnostic method
AU2376001A (en) Method for the manufacture of olefins
AU3393100A (en) Rescue apparatus
AU4304499A (en) Apparatus for air-treatment of products
AU2739399A (en) Photobioreactor apparatus
AU3245799A (en) Method for activating the functions of an electrical apparatus
AU6673700A (en) Combination 37-wire unilay stranded conductor and method and apparatus for forming the same
AU1924297A (en) Transposing apparatus for the manufacture of c.t.c. conductors
AU5368399A (en) Laminator apparatus
AU5855899A (en) Method for identifying substances for the treatment of c-jun-mediated disorders
AU2520299A (en) Method for the determination of prosthetic infections
AU4032799A (en) Device for the treatment of bottles
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU2001265759A1 (en) Method for the highly parallel analysis of polymorphisms

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase